Zhejiang research center launches first urine-based HPV test

Human papilloma virus (HPV) can cause cervical cancer.  9-valent vaccine can neutralize 90% of cancer-causing subtypes, but cannot protect women who have already been infected with HPV.

Chen Yiyou, Chief Scientist of Nuohui Health Research Center in Zhejiang, has designed a new test for HPV in urine. With this test, detection of the currently recognized high-risk viruses are possible. Sensitivity of HPV type16 and type18 are very high, and sensitivity of detection of precancerous lesions reaches 96.8%.

Sohu news release, December 24, 2019

Most popular posts:

This website stores cookies on your computer. These cookies are used to provide a more personalized experience and to track your whereabouts around our website in compliance with the European General Data Protection Regulation. If you decide to to opt-out of any future tracking, a cookie will be setup in your browser to remember this choice for one year.

Accept or Deny